Skip to content

Papa Turtle contains plant protease essence water to assist in the treatment of adolescent mild to moderate acne and reduce recurrence Clinical observation and research

Papa Turtle contains plant protease essence water to assist in the treatment of adolescent mild to moderate acne and reduce recurrence Clinical observation and research

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120652
Enrollment
Unknown
Registered
2026-03-18
Start date
2025-07-23
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild to moderate acne

Interventions

Experimental group:The subjects applied benzoyl peroxide externally to the affected areas of their skin, twice a day for 2 consecutive weeks
at the same time, they applied 2ml of Turtle Dad Dual Extract Control Oil and Repair Essence Water all over their face, twice a day (morning and evening), for 6 consecutive weeks.
Control group:The subjects applied benzoyl peroxide externally to the affected areas, twice a day for 2 consecutive weeks
at the same time, they applied a blank matrix externally, twice a day (morning and evening), for 6 consecutive weeks.

Sponsors

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 17 Years

Inclusion criteria

Inclusion criteria: 1. Adolescents aged 13 to 17, regardless of gender; 2. Patients diagnosed with mild to moderate acne (Pillsbury International Modified Classification System levels I-II); 3. Lesion sites are on the face; 4. Both patients and their families are willing to participate in and cooperate with this clinical trial, and have signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1.History of systematic use of glucocorticoids within one month prior to treatment, or topical use of corticosteroids and antifungal drugs within one week; 2.Merge patients with other facial skin diseases; 3.Merge serious primary diseases such as cardiovascular, hepatic, renal, and hematopoietic systems, as well as severe mental illness patients; 4.Patients who are allergic to research drugs; 5.Patients who are currently participating in clinical trials of other drugs.

Design outcomes

Primary

MeasureTime frame
Acne grading;Facial skin lesion count;Recurrence rate of facial skin lesions;

Secondary

MeasureTime frame
Sebaceous gland secretion measurement;Non invasive skin assessment;Researcher evaluation;Facial pores and red areas;

Countries

China

Contacts

Public ContactDeng Dan

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine

dengdan1234567@126.com+86 21 3808 8100

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026